IDG/Sanzay 1
by IDG/SANZAY Corporation 17 variants
IDG/Sanzay 1 (HC201) is a medical device (FDA Class II; FDA product code GFO, Activated Partial Thromboplastin) made by IDG/SANZAY Corporation, cleared under FDA 510(k) K022021 on 1 Nov 2002 and listed in FDA GUDID since 12 Jan 2024 (UDI-DI 00850053916199), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00850053916199 | Date12 Jan 2024 | StatusListed |
| United States | FDA 510(k)SESE | NumberK022021 | Date1 Nov 2002 | StatusActive |
Official records
- AccessGUDID record 00850053916199
- FDA 510(k) database K022021
From the FDA record
- Device description
- The IDG APTT-EA reagent is an in vitro diagnostic assay intended for use in determining activated partial thromboplastin time (APTT) and coagulation factor assays that are based on a modified APTT.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K022021 decided 1 Nov 2002 Active
- FDA GUDID UDI-DI 00850053916199 listed 12 Jan 2024 Listed
Timeline
- Cleared FDA 510(k) K022021
- Listed FDA GUDID 00850053916199
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- IDG/Sanzay
- Generic name
- Activated partial thromboplastin time (APTT) IVD, reagent
- Model / Ref / Catalog
- 1, HC201
- Primary DI / UDI-DI
- 00850053916199
- 510(k) Number
- FDA product code
- GFO
- GMDN term
- Activated partial thromboplastin time (APTT) IVD, reagent
- Device class
- Class II
- Regulation number
- 864.7925
- GUDID distribution status
- In Commercial Distribution